Infusion Pumps Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)

Infusion Pumps Market Trends & Growth Drivers

Shift to Home-Based Care Is Biggest Market Trend

• The biggest trend in the infusion pumps market is the growing preference of patients for home-based care.
• People suffering from chronic diseases have to visit the hospital multiple times a year, which takes a severe toll on their finances and mental health. Moreover, elderly people are unable to step out of their home that easily owing to reduced physical power and mobility.
• Patients of chronic diseases need long-term medication, which becomes easier with home-use infusion pumps.
• This is of special benefit to those suffering from chronic pain, diabetes, and cancer, which require regular drug administration.
• Moreover, these pumps can be integrated with AI, IoT, and other technologies to enable and consultation, as well as more-accurate dosing.
• With the surging emphasis on cost-effectiveness in the healthcare sector, there is a continuous shift of patients from expensive healthcare settings, including emergency and other hospital departments, to less-costly alternative sites, such as diabetes clinics/centers and home care settings.
• Such alternative healthcare settings offer greater convenience.
• Due to the rising availability of advanced insulin delivery devices, home infusion therapy is rapidly gaining acceptance among diabetic patients.
• Moreover, infusion insulin pumps provide an accurate dosage of insulin throughout the day; therefore, the popularity of home infusion therapy has grown significantly, globally.

Growing Prevalence of Chronic Diseases Is Biggest Market Driver

• The biggest market driver is the growing incidence of chronic diseases, especially cancer, long-term pain, and diabetes.
• As per the latest International Diabetes Federation World Atlas, 537 million people in the age group of 20 to 79 have diabetes around the world, and this number will grow to 783 million by 2045.
• Similarly, more than 50 million cancer cases are expected to be diagnosed across the globe in 2050, says the World Health Organization (WHO).
• The WHO also mentions than for every 10 people, 1 is diagnosed with chronic pain each year.
• All these conditions require long-term therapy, which is cumbersome with conventional syringes and pens, primarily because of their disposable nature and the inconvenience and phobia associated with repeated needle pricks.
• This makes infusion pumps useful at hospitals, as therapy with them require inserting the needle just once and affixing it in place with adhesive.
• Over time, based on the setting, the pump delivers a specific amount of drug directly into a major vein.
• The arrival of wearable infusion pumps has further enhanced convenience for patients and allowed them to be more mobile and be able to do their daily chores.

Stringent Regulations and Lengthy Approval Process Hamper Market Growth

• The biggest restraints for the infusion pumps market are the stringent safety and efficacy regulations and the lengthy approval process for medical products.
• The FDA and EMA have some of the strictest regulations for medical devices and pharmaceuticals around the world, and adhering to them requires extensive investments in R&D, several stages of clinical trials, and evaluation and re-evaluation of the results several times.
• Even after such effort, the risk of post-marketing-approval malfunction and product recall remains.
• This not only makes the products expensive but also restrict access to them by taking a long time for approval.

Infusion Pumps Market Analysis

Product Type Analysis

The accessories and consumables category holds the larger share in the infusion pumps market in 2024, of 60%. It is also expected to witness the higher CAGR, of 7.6%, during the forecast period. This is primarily due to the availability of a broad range of accessories and consumables and their repetitive purchases, across the globe. As the number of people with chronic diseases rises, the sale of infusion pump for hospital and home use will rise. With it will increase the demand for consumables and accessories for repeated purchase, thus driving the market in this category.

The report covers the following product types:

• Devices
  • Volumetric
  • Insulin
  • Enteral
  • Syringe
  • Ambulatory
  • Patient-controlled analgesia (PCA)
  • Implantable
• Accessories and Consumables (Larger and Faster-Growing Category)

Functionality Analysis

The demand for traditional infusion pumps is projected to witness the faster growth, at a CAGR of around 7.8%, during the forecast period. They also dominate the market in 2024, with a share of 55%. This is because the demand for these pumps is increasing for delivering pain medicines, antibiotics, chemotherapeutic drugs, and hydration fluids, in-home and long-term care settings.

The below-mentioned functionalities have been analyzed:

• Specialty
• Traditional (Larger and Faster-Growing Category)

Application Analysis

The diabetes management category accounts for the largest revenue share in the market in 2024, and it will also witness the fastest growth over the forecast period. This is attributed to the growing prevalence of diabetes and its complications across the globe. Furthermore, innovations in diabetes management wearable technology and extended infusion period are also responsible for the major adoption of these systems.

We have studied the below-mentioned applications:

• Chemotherapy/Oncology
• Diabetes Management (Largest and Fastest-Growing Category)
• Gastroenterology
• Pain Management/Analgesia
• Pediatrics/Neonatology
• Others

End User Analysis

Hospitals are the largest end users, with a share in 2024. This is attributed to hospitals being the preferred places for people to get treatment and diagnosis. This is why these medical centers witness the highest patient footfall, thereby requiring a large number of infusion pumps and huge volumes of consumables and accessories. Additionally, any adverse drug reaction is best dealt with at a hospital, which is a key reason they remain patients’ most-popular choice.

The home care settings category is expected to grow at the highest rate during the forecast period. The increased prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory diseases; high cost of hospitalization; and growth in the elderly population and patient pool are key factors for the rapid market expansion in this category.

Insights into the following end users have been provided:

• Hospitals (Largest Category)
• Homecare Settings (Fastest-Growing Category)
• Ambulatory Care Settings
• Others

Regional Analysis

North America is the largest market for infusion pumps, globally, generating 45% revenue in 2024. The dominance of the regional market is due to the presence of well-developed healthcare infrastructure, high acceptance of technologically improved products, and growth in the geriatric population.

Moreover, in Europe, diabetes is becoming more common among people of all ages. As per the WHO, by 2045, 1 in 10 people in the region will have this common endocrine disorder Therefore, the need for providing cost-effective and better healthcare solutions and services to the increasing diabetic population has raised the demand for insulin delivery devices in the region.

The APAC market will witness the fastest growth in the coming years, at 8.0% CAGR. The regional market is growing mainly due to the surging prevalence of lifestyle diseases including diabetes and obesity, the rising awareness about diabetes management, and the increasing healthcare spending. Moreover, expanding government efforts, particularly in populous countries like China and India, development in the field of contemporary healthcare infrastructure, and increasing understanding about the use of infusion pumps are further propelling the market in the region.

The following regions and countries are covered:

• North America (Largest Regional Market)
  • U.S. (Larger and Faster-Growing Country Market)
  • Canada
• Europe
  • Germany (Largest and Fastest-Growing Country Market)
  • Spain
  • U.K.
  • Italy
  • France
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • India (Fastest-Growing Country Market)
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest and Fastest-Growing Country Market)
  • Mexico
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest and Fastest-Growing Country Market)
  • South Africa
  • Rest of MEA

Infusion Pumps Market Share

The infusion pumps market is consolidated, due to the presence of several major players. This is itself because being a medical device intended for direct human contact, they are subject to stringent regulations for efficacy and patient safety. Thus, only established players with enough to spend on R&D offer these devices, which means high entry barriers for newcomers. Additionally, the major players enjoy strong brand loyalty and often operate under long-term contracts with healthcare providers, thus further limiting the scope for small, local and regional firms.

Infusion Pump Market News

• In June 2024, Becton, Dickinson and Company announced plans to acquire the critical care product group of Edwards Lifesciences in an USD 4.2-billion all-cash transaction. With this acquisition, BD will expand its smart, connected care solution portfolio, with the acquired unit being incorporated into its medical segment.
• In April 2024, Baxter International Inc. received the FDA’s approval for its Dose IQ safety software and Novum IQ high-volume infusion pump.
• In January 2024, Medtronic plc received the CE mark for its MiniMEd 780G insulin pump system with Simplera Sync, after receiving the FDA’s approval for it in April 2023.
• In August 2023, ICU Medical Inc. obtained the FDA’s approval for its LifeShield infusion safety software and Plum Duo infusion pump.